Data Collection of OCT and OCTA-based Ocular Measurements
NCT ID: NCT03887104
Last Updated: 2019-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
482 participants
OBSERVATIONAL
2019-02-08
2019-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Precision of OCT and OCTA-based Ocular Measurements
NCT03859310
Performance Evaluation of OCT and OCT Angiography-based Ocular Measurements (Optical Coherence Tomography)
NCT04437082
Comparison of OCT and OCTA-based Ocular Measurements to Those of Predicate
NCT03852485
Optical Coherence Tomography (OCT) Data Collection Study
NCT01459731
Retinal Investigation Using Optos OCT Device
NCT06846151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SD-OCT
Spectral Domain Optical Coherence Tomography for non-invasive, light-based, cross-sectional imaging of ocular structures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No retinal pathology
* No systemic disorders impacting the eye
* No ocular surgery or medical treatment of ocular condition
Exclusion Criteria
* Poor vision
* Clinical findings consistent with pathology
* Unable to complete the study
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Optovue
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eye Care Center
Pomona, California, United States
Eye Care Institute
Fort Lauderdale, Florida, United States
IOVS
Newark, New Jersey, United States
AMA Eye Physicians & Surgeons
Marysville, Ohio, United States
College of Optometry
Tahlequah, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200-53771
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.